BXP · BXP, Inc.

Track BXP — free

$63.17 -0.76 (-1.19%) At close · Sep 18

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$10.19B

159.66M

Up next

Next earnings call

Oct 28, 2026 Est · unconfirmed · in 5 wks

Latest filing: 10-Q

filed Aug 6, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

$3.52B

Trailing 12 months

Net income (TTM)

$296.79M

Trailing 12 months

Revenue growth YoY

+3.1%

Year over year

Operating margin

—

Trailing 12 months

P / E (TTM)

34.0

Trailing earnings · reciprocal yield 2.9%

FCF yield

—

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

—

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

+0.5%

Year over year · more shares

Price change (1Y)

-18.8%

Trailing year

Short interest

7.0%

Latest settlement · 9.3 days to cover

View all 115 metrics

Equibles Research

our published analysis of this company

Research Thesis July 14, 2026

Alexandria Real Estate Equities: stress event priced in, dividend reset is the test

Alexandria Real Estate Equities sits at a -38.8% trailing-twelve-month change and a -45.0% drawdown from its 52-week high after cutting its dividend from $1.32 to $0.72 and reporting zero public biotech leasing for the first quarter in company history. The peer office REIT cohort is reporting tightening markets and raising FFO midpoints, leaving ARE's stress specific to its public-biotech exposure — the setup turns on whether the 1.1 million square feet of leased vacant space delivers in September 2026, the $2.2 billion disposition program closes on pace, and public biotech leasing returns in Q2.

Equibles Rating

blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Sell Momentum Neutral Sentiment Neutral Fundamentals Strong Quant / Vol Moderate

Market backdrop VIX 14.8 · calm Equity put/call 0.58

Technical

price trend

Sell

50 / 200-day cross No cross

Price vs 200-day avg −0%

below

Price vs 50-day avg −7%

below

RSI (14) 35

neutral

MACD trend Negative

52-week position 45%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Neutral

1-month return −7%

trailing

6-month return +23%

trailing

YTD return −6%

this year

Relative strength +3%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $68 › 200d $63 — 50d above 200d

Institutional flow Accumulating

+2% holders QoQ · +78 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Rising

7.03% of float · ▲ +7.4% MoM · 9.3 days cover

Volume signal Reversal watch

High volume on a down day — possible exhaustion

Institution breadth Steady

554 holders — mid 3-yr range

Squeeze score 62

elevated · 0–100

Fundamentals

Strong

Revenue growth +2%

Y/Y

Gross margin 59%

contracting

EPS growth +1833%

Y/Y

Valuation P/E 34.3

below peers

Balance sheet $2.8B

net debt

Quant / Vol

risk profile

Moderate

Volatility 27%

annualized · 1-yr

Max drawdown −34%

past year

ATR 2.4%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the 8-K filed Jul 28, 2026

Third Quarter 2026

Projected EPS (diluted) Initiated $0.50 – $0.52

prior qtr $0.43 midpoint +18.6% QoQ

Projected FFO per share (diluted) Initiated $1.80 – $1.82

Full Year 2026

Projected EPS (diluted) Initiated $2.14 – $2.24

prior FY $1.74 midpoint +25.9% Y/Y

Projected FFO per share (diluted) Initiated $6.99 – $7.05

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell

2 · 5 · 0

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−0% Neutral

Price vs 50-day avg

−7% Bearish

RSI (14)

35 Neutral

MACD trend

Negative Bearish

52-week position

45% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Mixed

Trend (MA cross) No cross

50d $68 › 200d $63 — 50d above 200d

Institutional flow Accumulating

+2% holders QoQ · +78 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Rising

7.03% of float · ▲ +7.4% MoM · 9.3 days cover

Volume signal Reversal watch

High volume on a down day — possible exhaustion

Institution breadth Steady

554 holders — mid 3-yr range

Price context

position in its 52-week range

Range low $51 Now $63 · 45% Range high $78

vs 200-day avg 0% vs 50-day avg -7%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

REIT - Office — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
BXP BXP, Inc. this stock	$10.19B	-6.4%	+2.2%	34.3	7.0%
ARE Alexandria Real Estate Equities, Inc.	$9.22B	+8.9%	-2.9%	—	4.2%
VNO Vornado Realty Trust	$6.49B	+4.9%	+1.3%	1159.0	6.0%
CUZ Cousins Properties Inc	$4.65B	+9.7%	+16.0%	706.4	7.1%
KRC Kilroy Realty Corp	$3.98B	-8.4%	-2.0%	18.7	8.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

554

% held: 112.3%
Net QoQ: +8.7M sh
Top holder: COHEN & STEERS, INC.

Held Float

View

Held by Funds

Fund positions

564

View

Short & Settlement

Short Interest Rising

Shares short

11.2M

Days to cover: 9.3d
Change: +768.6K sh

View

Short Volume

Short vol %

47%

As of: Sep 18, 2026

Short Total

View

Fails to Deliver

FTD shares

7.2K

Value: $504.2K
As of: Aug 28, 2026

View

Off-Exchange

Off-exchange %

43.6%

Week of: Aug 10, 2026

Off-exch Lit

View

Smart Money

Congressional Trades Buy

Member

Alan Armstrong

Amount: $1.0K–$15.0K
Traded: Mar 27, 2026

View

Financials

Revenue (FY)

$3.5B

Net income (FY): $276.8M
EPS diluted: $1.74

View

Filings

SEC Filings

Latest

8-K

Filed: Aug 31, 2026
This year: 11

View

Proposed Sales

Value

$1.7M

Shares: 26.1K
Filed: Jun 9, 2026

View

Earnings & Events

Earnings Calls

Last call

Sep 15, 2026

View

Performance

	5D	20D	120D	MTD	YTD
BXP	-2.4%	-6.8%	+22.8%	-7.1%	-6.4%
SPY	-0.3%	-0.1%	+20.1%	-0.7%	+11.7%
vs SPY	-2.0%	-6.7%	+2.7%	-6.4%	-18.1%

Capital returns

Declared · upcoming

$0.70 / share · ex Sep 30, 2026

Paid (TTM)

$0.00 / share · 0 payouts

Dividend yield (TTM, derived)

— · no payout in the trailing year

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1037540 CUSIP 101121101 13F (30d) 15 filings 13 filers Visit website Investor relations

BXP · BXP, Inc.

Price & Indicators

Up next

Metrics snapshot

Equibles Research

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance

Capital returns